ENGLEWOOD CLIFFS, N.J., March 13 /PRNewswire-FirstCall/ -- EpiCept Corporation today announced that it will host a conference call to discuss full-year 2005 operating and financial results on Thursday, March 16, 2006 at 8:30 a.m. Eastern Standard Time. The call will follow the release of these financial results on Wednesday, March 15, 2006, after the closing of the market.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )
To listen to the conference call, please dial 800-498-5196 (United States and Canada) or 973-409-9254 (International). The access code for the call is 7149670. Please dial in approximately 10 minutes before the start of the conference call. You can access a live webcast of this conference on the Company's web site at http://www.epicept.com. The webcast will be archived for 90 days.
A playback of the call will be available from approximately 1:00 p.m. Eastern Standard Time on March 16, 2006 through March 23, 2006. You can access the playback at 877-519-4471 (United States or Canada) or 973-341-3080 (International). Please reference reservation number 7149670.
About EpiCept Corporation
EpiCept is an emerging pharmaceutical company focused on unmet needs in the treatment of pain and cancer. The company has a staged portfolio with several pain therapies in late-stage clinical trials, and a lead oncology compound (for AML) with demonstrated efficacy in a Phase III trial; the compound is intended for commercialization in Europe. EpiCept is based in New Jersey, and the company's R&D team in San Diego is pursuing a drug discovery program focused on novel approaches to apoptosis.
EPCT-GEN
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comEpiCept CorporationCONTACT: Robert W. Cook, of EpiCept Corporation, +1-201-894-8980,rcook@epicept.com; or Lev Janashvili, of Feinstein Kean Healthcare,+1-617-761-6731, lev.janashvili@fkhealth.com
Web site: http://www.epicept.com/
